Patents by Inventor Andrey Anisimov

Andrey Anisimov has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC USE OF VEGF-C AND CCBE1
    Publication number: 20210196795
    Abstract: The present invention relates to therapeutic methods, uses and compositions comprising CCBE1 and VEGF-C for treating disorders and conditions involving impaired lymphatic system, particularly lymphedema.
    Type: Application
    Filed: December 11, 2020
    Publication date: July 1, 2021
    Inventors: Kari ALITALO, Michael JELTSCH, Andrey ANISIMOV
  • THERAPEUTIC USE OF VEGF-C AND CCBE1
    Publication number: 20160193298
    Abstract: The present invention relates to therapeutic methods, uses and compositions comprising CCBE1 and VEGF-C for treating disorders and conditions involving impaired lymphatic system, particularly lymphedema.
    Type: Application
    Filed: August 13, 2014
    Publication date: July 7, 2016
    Inventors: Kari ALITALO, Michael JELTSCH, Andrey ANISIMOV
  • BIOMARKER FOR SENSITIVITY TO THERAPY WITH A NOTCH INHIBITOR
    Publication number: 20130039930
    Abstract: Described herein are materials and methods for identifying subjects that would benefit from Notch-targeted therapy.
    Type: Application
    Filed: June 8, 2012
    Publication date: February 14, 2013
    Inventors: Kari Alitalo, Andrey Anisimov, Masahiro Yamamoto